share_log

Reliq Health Technologies, Inc. Announces Six New Contracts in CA, FL and NV

Reliq Health Technologies, Inc. Announces Six New Contracts in CA, FL and NV

Reliq Health Technologies, Inc. 宣布在加利福尼亚州、佛罗里达州和内华达州
GlobeNewswire ·  2023/06/09 03:01

HAMILTON, Ontario, June 09, 2023 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) ("Reliq" or the "Company"), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it has signed six new contracts with physician practices in California, Florida and Nevada. These new contracts are expected to add over 3,000 new patients to Reliq's iUGO Care platform by the end of Q1 calendar year 2024, at an average revenue of $65 per patient per month.

安大略省汉密尔顿,2023 年 6 月 9 日(GLOBE NEWSWIRE)— Reliq Health Technologies Inc.(TSXV: RHT 或 OTC: RQHTF 或 WKN: A2AJTB) (”Reliq“或者”公司“)是一家快速发展的全球医疗保健技术公司,为数十亿美元的医疗保健市场开发创新的虚拟医疗解决方案。该公司很高兴地宣布,它已与加利福尼亚州、佛罗里达州和内华达州的医生诊所签署了六份新合同。预计到2024日历年第一季度末,这些新合同将为Reliq的iUGO Care平台增加3,000多名新患者,每位患者每月的平均收入为65美元。

"We are very pleased with our continued traction in California, Florida and Nevada," said Dr. Lisa Crossley, CEO at Reliq Health Technologies, Inc. "The southern US states are a particularly attractive market segment for Reliq due to demographics. With many older Americans choosing to move south in retirement, there is a very large population of Medicare-covered patients in these states who are eligible for Reliq's services. The three states where we have the largest number of patients – California, Florida and Texas – make up over 25% of the total US population, with over 90 million residents. The new clients will be using the iUGO Care Remote Patient Monitoring (RPM), Chronic Care Management (CCM) and Behavioural Health Integration (BHI) modules to improve health outcomes and reduce the cost of care for their chronic disease patients. We expect to add over 3,000 patients to the iUGO Care platform by the end of March 2024 through these contracts, at an average of $65 per patient per month with an expected 75% gross margin. All six practices will go live next month."

“我们对我们在加利福尼亚州、佛罗里达州和内华达州的持续关注感到非常满意,” Reliq Health Technologies, Inc.首席执行官丽莎·克罗斯利博士说,“由于人口结构原因,美国南部各州是Reliq特别有吸引力的细分市场。随着许多美国老年人在退休后选择向南移动,这些州有大量的医疗保险承保患者有资格获得Reliq的服务。我们患者人数最多的三个州——加利福尼亚州、佛罗里达州和德克萨斯州——占美国总人口的25%以上,居民超过9000万。新客户将使用iUGO Care远程患者监测(RPM)、慢性护理管理(CCM)和行为健康整合(BHI)模块来改善健康结果并降低慢性病患者的护理成本。我们预计,到2024年3月底,通过这些合同,iUGO Care平台将增加3,000多名患者,平均每位患者每月65美元,预计毛利率为75%。所有六种做法将在下个月上线。”

Reliq Health

Reliq 健康

Reliq Health Technologies is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq's powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the Frankfurt Stock Exchange under the WKN:A2AJTB.

Reliq Health Technologies是一家快速发展的全球医疗保健技术公司,专门为数十亿美元的医疗保健市场开发创新的虚拟医疗解决方案。Reliq 强大的 iUGO Care 平台支持护理协调和基于社区的虚拟医疗保健。iUgo Care 允许复杂患者在家接受高质量的护理,改善健康结果,提高患者和家属的生活质量并降低医疗服务提供成本。iUgo Care 提供对远程患者监测数据的实时访问,使护理团队能够及时进行干预,防止昂贵的再入院和急诊就诊。Reliq Health Technologies在多伦多证券交易所风险投资公司上市,股票代码为RHT,在场外交易所交易代码为RQHTF,在法兰克福证券交易所上市,代码为WKN: A2AJTB。

ON BEHALF OF THE BOARD
"Dr. Lisa Crossley"
CEO and Director

代表董事会
“丽莎·克罗斯利博士”
首席执行官兼董事

For further information please contact:

欲了解更多信息,请联系:

Company Contact
Investor Relations at ir@reliqhealth.com

公司联系人
投资者关系部位于 ir@reliqhealth.com

US Investor Relations Contact
Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
646-829-9701
shamsian@lythampartners.com

美国投资者关系联系人
投资者关系
莱瑟姆合伙人有限责任公司
本·沙姆西安
纽约 | 菲尼克斯
646-829-9701
shamsian@lythampartners.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

多伦多证券交易所风险投资交易所及其监管服务提供商(该术语在多伦多证券交易所风险投资交易所的政策中定义)均不对本新闻稿的充分性或准确性承担责任。

Cautionary Statements Regarding Forward Looking Information

关于前瞻性信息的警示声明

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

根据适用的证券法的规定,本新闻稿中的某些陈述构成前瞻性陈述。所有非历史事实的陈述,包括但不限于有关未来估计、计划、计划、预测、目标、假设、预期或未来业绩信念的陈述,均为 “前瞻性陈述”。

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

我们提醒您,此类 “前瞻性陈述” 涉及已知和未知的风险和不确定性,可能导致实际和未来事件与此类陈述中的预期存在重大差异。

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

前瞻性陈述包括但不限于与商业运营有关的陈述,包括技术开发、预期收入、预计市场规模以及其他基于未来业绩预测、尚未确定的金额估计和管理假设的信息。

Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

Reliq Health Technologies In公司“) 除非法律要求,否则不打算也不承担任何义务更新这些前瞻性陈述。这些前瞻性陈述涉及与技术开发和营销活动、公司在技术开发方面的历史经验、未投保的风险等有关的风险和不确定性。实际结果可能与此类前瞻性陈述所表达或暗示的结果存在重大差异。

SOURCE: Reliq Health Technologies Inc.

资料来源:Reliq 健康科技公司


声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发